Skip to Content

Join the 'Intraocular Hypertension' group to help and get support from people like you.

Intraocular Hypertension News

Aerie Pharmaceuticals Announces U.S. FDA Approval of Rhopressa (netarsudil ophthalmic solution) 0.02% for Patients with Open-Angle Glaucoma or Ocular Hypertension

Posted 19 Dec 2017 by

IRVINE, Calif.--(BUSINESS WIRE)--Dec. 18, 2017-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), an ophthalmic pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced that the U.S. Food and Drug Administration (FDA) has approved Rhopressa® (netarsudil ophthalmic solution) 0.02% for the lowering of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. A link to the full product label is available on the Aerie website at The FDA approval decision was made two months ahead of the scheduled PDUFA (Prescription Drug User Fee Act) goal date of February 28, 2018. “The approval of once-daily Rhopressa® represents the single greatest achievement i ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Intraocular Hypertension, Glaucoma/Intraocular Hypertension, Rhopressa, Netarsudil

Smartphone Blood-Pressure 'App' Often Wrong, Study Finds

Posted 2 Mar 2016 by

WEDNESDAY, March 2, 2016 – A popular "app" that uses your smartphone to check your blood pressure is inaccurate, missing high blood pressure readings in four out of every five patients tested, researchers report. Instant Blood Pressure promises to provide an estimated blood pressure reading if users place their smartphone on the left side of their chest while placing their index finger on the phone's camera, said lead researcher Dr. Timothy Plante, an internist with Johns Hopkins University School of Medicine in Baltimore. But close to 80 percent of people with clinically high blood pressure, defined as 140/90, showed normal blood pressure with the app, his team found. "If someone with high blood pressure is using Instant Blood Pressure to follow their blood pressure at home, more times than not it's going to tell them they're fine," Plante said. The $4.99 app is no longer for sale on ... Read more

Related support groups: High Blood Pressure, Hypertension, Intraocular Hypertension, Hypertensive Emergency, Hypertensive Congestive Heart Failure, Hypertensive Heart Disease

Including Pharmacist on Medical Team May Aid Blood Pressure Control

Posted 7 Aug 2015 by

FRIDAY, Aug. 7, 2015 – Pharmacists can play an important role in helping patients control high blood pressure, a new study finds. Researchers followed 625 racially and ethnically diverse Americans with uncontrolled high blood pressure who were seen at 32 medical offices in 15 states. The patients were either cared for by a doctor only, or by a medical team that included a pharmacist. "Clinical pharmacists were able to contribute to the care team by tailoring blood pressure medications for each patient and spent extra time educating patients on how to decrease their blood pressure," study corresponding author Tyler Gums, a postdoctoral researcher in the University of Iowa College of Pharmacy, said in a university news release. High blood pressure increases the likelihood of heart disease and stroke, two of the leading causes of death for Americans, the study authors noted. The ... Read more

Related support groups: High Blood Pressure, Hypertension, Benicar HCT, Exforge, Azor, Diovan HCT, Hyzaar, Lotrel, Avalide, Intraocular Hypertension, Hydrochlorothiazide/Lisinopril, Maxzide, Edarbyclor, Micardis HCT, Dyazide, Amlodipine/Benazepril, Hydrochlorothiazide/Triamterene, Hydrochlorothiazide/Losartan, Tarka, Ziac

Alcon Announces FDA Approval of Simbrinza Suspension, a New Beta Blocker-Free, Fixed-Combination Therapy for Glaucoma Patients

Posted 23 Apr 2013 by

Basel, April 19, 2013 – Alcon, the global leader in eye care and a division of Novartis, announces US FDA approval for Simbrinza Suspension, indicated for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.4 Elevated IOP is the only modifiable risk factor for glaucoma. Glaucoma is a group of eye diseases that lead to progressive damage of the optic nerve5 and can result in gradual, irreversible loss of vision, and eventually blindness, if left untreated.6 Glaucoma affects more than 2.2 million Americans7 and is the second-leading cause of preventable blindness worldwide.8 Simbrinza is a fixed-dose combination medication that offers a wide range of treatment possibilities due to its strong efficacy and ability to decrease elevated IOP by 21- 35%.1,2,3 In addition, it is the only available, fixed-dose combination ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Intraocular Hypertension, Brimonidine, Brinzolamide

Common Eye Condition Linked to Elevated Eye Pressure

Posted 10 Nov 2010 by

WEDNESDAY, Nov. 10 – A eye condition called corneal arcus may be associated with elevated eye pressure, which in turn is a risk factor for glaucoma, a new study suggests. It also found that corneal arcus – in which a ring of fats accumulates around the cornea – appears to be common in middle-aged and older adults. Corneal arcus may be associated with cardiovascular disease. Researchers examined the eyes of 3,015 people, aged 40 to 80, and found that corneal arcus was present in the right eyes of 57.9 percent of them. After adjusting for a number of factors, the researchers found that eyes with corneal arcus tended to have higher intraocular (inside the eye) pressure, thicker corneas and altered corneal curvatures. "There is no known explanation for the association of corneal arcus with higher intraocular pressure," wrote Dr. Renyi Wu, of the Singapore Eye Research Institute, and ... Read more

Related support groups: Intraocular Hypertension

Relieving Eye Pressure May Slow Glaucoma

Posted 9 Aug 2010 by

MONDAY, Aug. 9 – Patients with glaucoma who have more rapid visual field change than other patients may benefit from a reduction of pressure within the eyeball, new research suggests. In the study, 216 patients with open-angle glaucoma were given standard treatment for controlling intraocular pressure (a targeted reduction of 30 percent or more) and were followed up with re-examination every four months. Patients whose glaucoma continued to progress received treatment to achieve an additional 20 percent or more reduction in intraocular pressure. Being older and having abnormal levels of anticardiolipin antibody (which is an antibody directed against a certain protein in the body) were associated with a more rapid rate of visual change. But reducing intraocular pressure appeared to slow the rate at which some of these patients experienced declines in visual field, the study authors ... Read more

Related support groups: Intraocular Hypertension, Glaucoma/Intraocular Hypertension

Ask a Question

Further Information

Related Condition Support Groups

Hypertensive Retinopathy, Intracranial Hypertension

Related Drug Support Groups

Lumigan, latanoprost, Travatan, Xalatan, Combigan, Travatan Z, Alphagan, Azopt, Cosopt, view more... brimonidine, Zioptan, dorzolamide, Alphagan P, Timoptic, travoprost, Betagan, Simbrinza, brinzolamide, Trusopt, Rescula, Isopto Carbachol, Timoptic Ocudose, Pilopine-HS, bimatoprost, levobunolol, dipivefrin, Cosopt PF, tafluprost, carbachol, dorzolamide / timolol, Piloptic-3, Piloptic-4, Piloptic-6, Timoptic-XE, Betimol, AK-Beta, Akarpine, Betoptic, Betoptic-S, Qoliana, Izba, Ocupress, Piloptic-2, Carboptic, Piloptic-1, Pilocar, metipranolol, unoprostone, brimonidine / timolol, brimonidine / brinzolamide, netarsudil, Propine, OptiPranolol, Isopto Carpine, Istalol, Pilostat, Carbastat, Miostat, AK-Pro, Betagan C-Cap, Adsorbocarpine, Pilagan with C Cap, Ocu-Carpine, Ocusert, Piloptic-1 / 2, Rhopressa